Literature DB >> 34079004

Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors.

Nairveen Ali1,2, Christian Bolenz3, Tilman Todenhöfer4, Arnulf Stenzel4, Peer Deetmar5, Martin Kriegmair6, Thomas Knoll7, Stefan Porubsky8, Arndt Hartmann9, Jürgen Popp1,2, Maximilian C Kriegmair10, Thomas Bocklitz11,12.   

Abstract

Bladder cancer is one of the top 10 frequently occurring cancers and leads to most cancer deaths worldwide. Recently, blue light (BL) cystoscopy-based photodynamic diagnosis was introduced as a unique technology to enhance the detection of bladder cancer, particularly for the detection of flat and small lesions. Here, we aim to demonstrate a BL image-based artificial intelligence (AI) diagnostic platform using 216 BL images, that were acquired in four different urological departments and pathologically identified with respect to cancer malignancy, invasiveness, and grading. Thereafter, four pre-trained convolution neural networks were utilized to predict image malignancy, invasiveness, and grading. The results indicated that the classification sensitivity and specificity of malignant lesions are 95.77% and 87.84%, while the mean sensitivity and mean specificity of tumor invasiveness are 88% and 96.56%, respectively. This small multicenter clinical study clearly shows the potential of AI based classification of BL images allowing for better treatment decisions and potentially higher detection rates.

Entities:  

Year:  2021        PMID: 34079004     DOI: 10.1038/s41598-021-91081-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  1 in total

1.  Is there a learning curve for photodynamic diagnosis of bladder cancer with hexaminolevulinate hydrochloride?

Authors:  Stavros Gravas; Kostas Efstathiou; Ioannis Zachos; Michael D Melekos; Vassilios Tzortzis
Journal:  Can J Urol       Date:  2012-06       Impact factor: 1.344

  1 in total
  1 in total

Review 1.  Advances in Diagnosis and Therapy for Bladder Cancer.

Authors:  Xinzi Hu; Guangzhi Li; Song Wu
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.